Table 2.
Specifications of studies included in the umbrella review.
First author | Country | Sample size | Prevalence of PTSD | Number of articles | Subjects | Number of articles related to COVID-19 | Quality assessment | Hetero geneity |
---|---|---|---|---|---|---|---|---|
de Pablo GS (20) | UK | 470 | 7.7% (95% CI: 5.6–10.5%) | 115 | Nurses, Physicians, Medical Students, Social Workers | 1 | Moderate | I2 <0.001 |
Marvaldi M (21) | France | 23,432 | 21.5% (95%CI, 11.2–31.8%), | 70 | Physicians Nurses | 6 | Critically low | I2 = 99.62% |
Fan FC (22) | China | 17,153 | 19% (95% CI: 6.4–44.8) | 130 | Healthcare workers | 3 | Critically low | P = 0.022 |
Cénat JM (23) | Canada | 4,196 | 21% (95% CI: 0.5–57) | 55 | Healthcare workers | 4 | Low | I2 = 99.72 |
Batra K (24) | USA | 3,676 | 11.4% (95% CI: 3.6–30.9%) | 65 | Healthcare workers | 6 | Moderate | I2 = 99.2% |
Li Y (25) | UK | 97,333 | 21.5% (95% CI: 10.5–34.9%) | 65 | Healthcare workers | 9 | Moderate | I2 = 99.7% |
Krishnamoorthy Y (26) | India | 171,571 | 13% (95% CI: 11–16%) | 50 | Healthcare workers | 2 | Moderate | NA |
NA, Not Applicable.